Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

For patients with mild asthma with a low sputum eosinophil level

Mometasone, Tiotropium Do Not Top Placebo in Mild Asthma

And budesonide-formoterol superior to albuterol for prevention of asthma exacerbations
The risk for spontaneous abortion is increased among early pregnancies with incident exposure to benzodiazepines

Risk for Miscarriage Up With Benzodiazepine Use in Early Pregnancy

Risk similar for exposure to short-acting, long-acting benzodiazepines during early pregnancy
The selective Bruton's tyrosine kinase inhibitor evobrutinib at a dose of 75 mg once daily is associated with fewer enhancing lesions during weeks 12 through 24 among patients with relapsing multiple sclerosis

AAN: Oral BTK Inhibitor Superior to Placebo in Multiple Sclerosis

Fewer enhancing lesions seen in weeks 12 to 24 for 75 mg evobrutinib once daily versus placebo
A prognostic model can predict the risk for seizures in pregnant women with epilepsy on medication

Tool Predicts Seizure Risk During, After Pregnancy

Risk for seizures predicted for pregnant women with epilepsy on medication
When pharmacies close

Heart Patients at Risk When Pharmacies Close

Study shows link between pharmacy closures and medication noncompliance among patients with CVD
Fournier gangrene is a safety concern for adults with diabetes receiving treatment with sodium-glucose cotransporter-2 inhibitors

Fournier Gangrene Is Safety Concern With SGLT2 Inhibitors

FDA identified 55 cases of FG in patients on SGLT2 inhibitors from March 2013 through January 2019
For patients with psoriasis treated with systemic medications

Infection Risk Lower With Certain Psoriasis Treatments

Risk for serious infection reduced for new users of apremilast, etanercept, ustekinumab versus methotrexate
For internal medicine residents

Prior Training Increases Internists’ Knowledge of PrEP for HIV

IM residents with training report more frequent prescribing, higher comfort level in educating patients
Isradipine does not appear to slow progression of disability in patients with de novo Parkinson disease

AAN: Isradipine Offers No Benefit in Parkinson Disease

No significant treatment effect seen in UPDRS Part I to III score measured in the ON state
For patients with aquaporin-4-immunoglobulin G-positive neuromyelitis optica spectrum disorder

AAN: Eculizumab Reduces Risk for Relapse in Neuromyelitis Optica

But no significant between-group difference noted in measures of disability progression